GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shaperon Inc (XKRX:378800) » Definitions » PS Ratio

Shaperon (XKRX:378800) PS Ratio : 218.76 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shaperon PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shaperon's share price is ₩2055.00. Shaperon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩9.39. Hence, Shaperon's PS Ratio for today is 218.76.

The historical rank and industry rank for Shaperon's PS Ratio or its related term are showing as below:

XKRX:378800' s PS Ratio Range Over the Past 10 Years
Min: 46.52   Med: 235.26   Max: 983.16
Current: 218.76

During the past 5 years, Shaperon's highest PS Ratio was 983.16. The lowest was 46.52. And the median was 235.26.

XKRX:378800's PS Ratio is ranked worse than
90.52% of 1002 companies
in the Biotechnology industry
Industry Median: 9.495 vs XKRX:378800: 218.76

Shaperon's Revenue per Sharefor the three months ended in Mar. 2024 was ₩0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩9.39.

During the past 12 months, the average Revenue per Share Growth Rate of Shaperon was -90.80% per year.

Back to Basics: PS Ratio


Shaperon PS Ratio Historical Data

The historical data trend for Shaperon's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaperon PS Ratio Chart

Shaperon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
- - - 71.22 399.74

Shaperon Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.47 734.53 714.29 399.74 368.85

Competitive Comparison of Shaperon's PS Ratio

For the Biotechnology subindustry, Shaperon's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaperon's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shaperon's PS Ratio distribution charts can be found below:

* The bar in red indicates where Shaperon's PS Ratio falls into.



Shaperon PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Shaperon's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2055.00/9.394
=218.76

Shaperon's Share Price of today is ₩2055.00.
Shaperon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩9.39.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Shaperon  (XKRX:378800) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Shaperon PS Ratio Related Terms

Thank you for viewing the detailed overview of Shaperon's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shaperon (XKRX:378800) Business Description

Traded in Other Exchanges
N/A
Address
Gangnam Ace Tower G9, Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu, Seoul, KOR, 06373
Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient's quality of life by developing safe and efficacious drugs and immunotherapies.

Shaperon (XKRX:378800) Headlines

No Headlines